The U.S. Food and Drug Administration has hired a former executive from Mylan Pharmaceuticals as a senior communications advisor.
According to a report in The Hill, Nina Devlin, who was the head of global communications at Mylan, took over the role on Oct. 15. Devlin served in that role when Mylan was mired in allegations that the company pushed competitors out of the market for EpiPens so it could overcharge customers.
Mylan ultimately reached a $465 million settlement with the Justice Department after it accused the company of overcharging the government for EpiPens, but the company did not admit any wrongdoing.
In regards to her new position, Devlin said that she is supportive of the FDA’s fight against the opioid epidemic.